Behavioral evidence for mu-opioid and 5-HT2A receptor interactions (Q44342529)

2 December 2017

Behavioral evidence for mu-opioid and 5-HT2A receptor interactions (English)

1 reference

2 December 2017

0 references

Gerard J Marek

1

1 reference

PubMed ID

12909198

2 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

474

1 reference

2 December 2017

1

1 reference

2 December 2017

77-83

1 reference

‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity☆

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Buprenorphine treatment of refractory depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Possible antidepressive effects of opioids: action of buprenorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Organic mood syndrome associated with detoxification from methadone maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Buprenorphine has potent kappa opioid receptor antagonist activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Opiate receptor localization in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

The role of the accessory abducens nucleus in the rabbit nictitating membrane response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Kappa antagonist properties of buprenorphine in the shock titration procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Pharmacological mechanisms of opioid analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Effects of morphine and LSD on the classically conditioned nictitating membrane response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

A novel augmentation strategy for treating resistant major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Head twitches induced by LSD and quipazine: Similarities and differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901971-X

10.1016/S0014-2999(03)01971-X

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12909198